CDC6 and CDT1, for instance, positively correlated with various cycle- and proliferation-related pathways, such as E2F targets and G2M checkpoint, indicating that they regulate cancer development by activating these pathways (Figure 3D). The gene discussed is CDT1; the disease is cancer.